Arimidex 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FB4NE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,619
Award facts
- Contract value 100% obligated
- $20,619.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued by the Defense Logistics Agency on November 3, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $20,619.19 for the supply of Arimidex 1 mg tablets (30-count packaging). The contract is classified as a non-set-aside competitive award with an ultimate completion date of November 4, 2025. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain.
This delivery order represents a task order issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vehicle running through December 2026. The IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard. The DLA Troop Support is concurrently planning Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple anticipated awards across separate regions, positioning AmerisourceBergen to compete for continued strategic pharmaceutical support roles.
Quick answers
Who was awarded contract SPE2DR26FB4NE?
SPE2DR26FB4NE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FB4NE worth?
The government has obligated $20,619 on SPE2DR26FB4NE.
Is contract SPE2DR26FB4NE an order under another contract?
Yes. SPE2DR26FB4NE is a delivery order under SPE2DR25D2208, an indefinite delivery contract.
Was contract SPE2DR26FB4NE competed?
The extent of competition for SPE2DR26FB4NE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award